Last reviewed · How we verify
Klebsiella Pneumoniae Osteomyelitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Cefaprin · Bristol-Myers Squibb
- Tobi · Novartis
- Vantobra · Pfizer
- Nebcin · University Hospital, Lille
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Rocephin · Generic (originally Roche)
- Ceftazidim · Tel-Aviv Sourasky Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Klebsiella Pneumoniae Osteomyelitis patent landscape — cliff calendar, originator estates, attackable patents
- Klebsiella Pneumoniae Osteomyelitis treatment landscape brief
- Klebsiella Pneumoniae Osteomyelitis treatment updates RSS
Frequently asked questions about Klebsiella Pneumoniae Osteomyelitis
What drugs treat Klebsiella Pneumoniae Osteomyelitis?
Tracked treatments include Ramycin, Cefaprin, Tobi, Vantobra, Nebcin, Ceftriaxon, Fortaz, Rocephin.
What is the treatment for Klebsiella Pneumoniae Osteomyelitis?
Standard treatment for Klebsiella Pneumoniae Osteomyelitis includes Ramycin, Cefaprin, Tobi, Vantobra, Nebcin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Klebsiella Pneumoniae Osteomyelitis patent cliff · Klebsiella Pneumoniae Osteomyelitis CI report
- Treatment: Ramycin
- Treatment: Cefaprin · Bristol-Myers Squibb
- Treatment: Tobi · Novartis
- Treatment: Vantobra · Pfizer
- Treatment: Nebcin · University Hospital, Lille
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing